Literature DB >> 23680581

Opioid withdrawal syndrome after treatment with low-dose extended-release oxycodone and naloxone in a gastric cancer patient with portal vein thrombosis.

Jung Hun Kang, Gyeong-Won Lee, Seong Hoon Shin, Eduardo Bruera.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23680581     DOI： 10.1016/j.jpainsymman.2013.02.009

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN： 0885-3924            Impact factor:   3.612


× No keyword cloud information.
  8 in total

1.  Complications with oxycodone and naloxone.

Authors:  Alicia Ward; Michaela Del Campo; Kathy Hauser
Journal:  Aust Prescr       Date:  2017-08-01

2.  High dosage of a fixed combination oxycodone/naloxone prolonged release: efficacy and tolerability in patients with chronic cancer pain.

Authors:  Francesco Amato; Silvia Ceniti; Sergio Mameli; Giovanni M Pisanu; Renato Vellucci; Vincenzo Palmieri; Leonardo Consoletti; Dorotea Magaldi; Paolo Notaro; Claudio Marcassa
Journal:  Support Care Cancer       Date:  2017-05-03       Impact factor: 3.603

3.  Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study.

Authors:  Jordi Barrachina; Cesar Margarit; Javier Muriel; Santiago López-Gil; Vicente López-Gil; Amaya Vara-González; Beatriz Planelles; María-Del-Mar Inda; Domingo Morales; Ana M Peiró
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

4.  Spontaneously reported adverse drug events related to tapentadol and oxycodone/naloxone in Australia.

Authors:  Carmen Abeyaratne; Samanta Lalic; J Simon Bell; Jenni Ilomäki
Journal:  Ther Adv Drug Saf       Date:  2018-03-25

Review 5.  Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction.

Authors:  Wojciech Leppert
Journal:  Drug Des Devel Ther       Date:  2015-04-16       Impact factor: 4.162

6.  Oxycodone/Naloxone: role in chronic pain management, opioid-induced constipation, and abuse deterrence.

Authors:  Anne Z DePriest; Katie Miller
Journal:  Pain Ther       Date:  2014-05-06

7.  Naldemedine in Japanese patients with opioid-induced constipation and chronic noncancer pain: open-label Phase III studies.

Authors:  Yoji Saito; Takaaki Yokota; Masatsugu Arai; Yukio Tada; Masahiko Sumitani
Journal:  J Pain Res       Date:  2018-12-24       Impact factor: 3.133

8.  Analgesic effectiveness and tolerability of oral oxycodone/naloxone and pregabalin in patients with lung cancer and neuropathic pain: an observational analysis.

Authors:  Stefano De Santis; Cristina Borghesi; Serena Ricciardi; Daniele Giovannoni; Alberto Fulvi; Maria Rita Migliorino; Claudio Marcassa
Journal:  Onco Targets Ther       Date:  2016-07-04       Impact factor: 4.147
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.